PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.37
2 yrs 2 m
1%
533.05 Crs
1% on or before 1M, Nil after 1M
Mid Growth
8.56
SIP 100 & Lumpsum 500
BSE HEALTH CARE - TRI
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk